Zine News

Intellia Therapeutics to Present at August Healthcare Investor Conference

CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present at the following upcoming healthcare conference in August:

Publicaciones relacionadas

Botón volver arriba
Cerrar